{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:12Z","timestamp":1761100992786,"version":"build-2065373602"},"reference-count":101,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.hoc.2008.07.012","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T09:21:01Z","timestamp":1225185661000},"page":"839-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prognostic Systems for Lymphomas"],"prefix":"10.1016","volume":"22","author":[{"given":"Anna","family":"Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2008.07.012_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinternmed.2007.125","article-title":"Ongoing improvement in outcomes for patients diagnosed as having non-hodgkin lymphoma from the 1990s to the early 21st century","volume":"168","author":"Pulte","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib2","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia","volume":"23","author":"Sehn","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"The international non-hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib4","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V86.4.1460.bloodjournal8641460","article-title":"International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades","volume":"86","author":"Hermans","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.1994.12.7.1343","article-title":"Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma","volume":"12","author":"Lopez-Guillermo","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib6","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1200\/JCO.1999.17.8.2499","article-title":"Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients\u2013a study of the Groupe d'Etude des Lymphomes de l'Adulte","volume":"17","author":"Decaudin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib7","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/annonc\/mdi269","article-title":"Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems","volume":"16","author":"Perea","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib8","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib9","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-hodgkin's lymphomas","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib10","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","volume":"15","author":"Savage","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2005.05478.x","article-title":"The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas","volume":"129","author":"Sonnen","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.hoc.2008.07.012_bib13","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","article-title":"Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma","volume":"103","author":"Escal\u00f3n","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.07.012_bib14","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma","volume":"15","author":"Ansell","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib15","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2005-09-3600","article-title":"AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy","volume":"107","author":"Mounier","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib16","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1080\/10428190600757894","article-title":"The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma","volume":"47","author":"Micallef","year":"2006","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.hoc.2008.07.012_bib17","first-page":"3562","article-title":"The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA Trial","volume":"92","author":"Blay","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1994.12.7.1340","article-title":"Is the International Prognostic Index for aggressive lymphoma patients useful for follicular lymphoma patients?","volume":"12","author":"Bastion","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib19","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1996.14.4.1269","article-title":"Mantle-cell lymphoma: a population-based clinical study","volume":"14","author":"Velders","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.leu.2401121","article-title":"Mantle cell lymphoma: a retrospective study of 121 cases","volume":"12","author":"Samaha","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2008.07.012_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0959-8049(97)10056-9","article-title":"Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients","volume":"34","author":"Oinonen","year":"1998","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.hoc.2008.07.012_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":"Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network","volume":"131","author":"Tiemann","year":"2005","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.hoc.2008.07.012_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib24","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage IE\/IIE extranodal NK\/T-cell lymphoma, nasal type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib25","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular Lymphoma International Prognostic Index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2006.05970.x","article-title":"Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index","volume":"133","author":"Moller","year":"2006","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.hoc.2008.07.012_bib27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/asheducation-2006.1.295","article-title":"Optimal use of prognostic factors in non-hodgkin lymphoma","author":"Sehn","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.hoc.2008.07.012_bib29","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2006-01-013367","volume":"108","author":"Buske","year":"2006","journal-title":"Blood"},{"year":"2001","series-title":"Pathology and genetics of tumours of Haematopoietic and Lymphoid tissues","author":"Jaffe","key":"10.1016\/j.hoc.2008.07.012_bib30"},{"key":"10.1016\/j.hoc.2008.07.012_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0609.1998.tb01023.x","article-title":"Diffuse large B-cell lymphoma: Is morphologic subdivision useful in clinical management?","volume":"60","author":"Salar","year":"1998","journal-title":"Eur J\u00a0Haematol"},{"key":"10.1016\/j.hoc.2008.07.012_bib32","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood-2002-07-2298","article-title":"A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival","volume":"101","author":"Hans","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib33","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/annonc\/mdl039","article-title":"Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience","volume":"17","author":"Ganti","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib34","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/asheducation-2005.1.267","article-title":"Aggressive Peripheral T-Cell Lymphomas (Specified and Unspecified Types)","volume":"2005","author":"Savage","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.hoc.2008.07.012_bib36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V84.4.1043.1043","article-title":"Prognostic value of chromosomal abnormalities in follicular lymphoma","volume":"84","author":"Tilly","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/gcc.10314","article-title":"Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas","volume":"39","author":"Hoglund","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.hoc.2008.07.012_bib38","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood.V99.7.2285","article-title":"The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile","volume":"99","author":"Huang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib39","first-page":"2133","article-title":"The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome","volume":"9","author":"Barrans","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2008.07.012_bib40","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib41","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":"The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC rearrangement","volume":"92","author":"Le Gouill","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2008.07.012_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/\/c-MYC translocation generally have a poor prognosis","volume":"19","author":"Kanungo","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.hoc.2008.07.012_bib43","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","article-title":"Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma","volume":"93","author":"Gascoyne","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/348334a0","article-title":"Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death","volume":"348","author":"Hockenbery","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2008.07.012_bib45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2005.02.4786","article-title":"Prognostic biomarkers in diffuse large B-cell lymphoma","volume":"24","author":"Lossos","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood.V87.1.265.265","article-title":"Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)","volume":"87","author":"Hermine","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V90.1.244","article-title":"Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-hodgkin's lymphoma","volume":"90","author":"Gascoyne","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib48","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2002-11-3442","article-title":"Rituximab plus CHOP (R-CHOP) overcomes bcl-2\u2013associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)","volume":"101","author":"Mounier","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib49","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2002-07-2009","article-title":"Cell cycle deregulation in B-cell lymphomas","volume":"101","author":"Sanchez-Beato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/path.945","article-title":"p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome","volume":"195","author":"Pescarmona","year":"2001","journal-title":"Journal of Pathology"},{"key":"10.1016\/j.hoc.2008.07.012_bib51","first-page":"1085","article-title":"Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell Non-hodgkin's lymphoma","volume":"5","author":"Moller","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2008.07.012_bib52","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood.V71.4.1157.1157","article-title":"Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67","volume":"71","author":"Grogan","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib53","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V83.6.1460.1460","article-title":"Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial","volume":"83","author":"Miller","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00277-004-0855-x","article-title":"Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma\u2014a Nordic Lymphoma Group study","volume":"83","author":"Jerkeman","year":"2004","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.hoc.2008.07.012_bib55","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2007-10-117010","article-title":"Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group","volume":"111","author":"Determann","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib56","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic Score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib57","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","author":"Cuadros","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.hoc.2008.07.012_bib59","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1056\/NEJMra042342","article-title":"Microarray analysis and tumor classification","volume":"354","author":"Quackenbush","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2008.07.012_bib61","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2006.09.4490","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications\u2013a study from the lunenburg lymphoma biomarker consortium","volume":"25","author":"de Jong","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib62","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib63","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.hoc.2008.07.012_bib64","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/blood-2005-02-0687","article-title":"Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach","volume":"106","author":"Abramson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib65","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib66","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib67","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib68","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib69","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood.V98.4.945","article-title":"Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma","volume":"98","author":"Lossos","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib70","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1182\/blood-2005-10-4222","article-title":"Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study","volume":"107","author":"Winter","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib71","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib72","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib74","first-page":"341","article-title":"Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays","volume":"90","author":"Zinzani","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2008.07.012_bib75","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2006.05.5897","article-title":"Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma","volume":"24","author":"van Imhoff","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2002-04-1286","article-title":"Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma","volume":"101","author":"Colomo","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib77","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood-2005-04-1603","article-title":"Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.","volume":"106","author":"Moskowitz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib78","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2006-09-047068","article-title":"Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy","volume":"109","author":"Nyman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib79","first-page":"348","article-title":"Gene expression signatures predict overall survial in diffuse large B cell lymphoma treated with rituximab and chop-like chemotherapy","volume":"110","author":"Lenz","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.hoc.2008.07.012_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2008.188","article-title":"The expression of 16 genes related to the cell of origine and immune response predicts survival in elderly patients with Diffuse large B-cell lymphoma treated with CHOP and Rituximab","author":"Jais","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2008.07.012_bib81","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","article-title":"Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma","volume":"25","author":"Glas","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib82","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2008.07.012_bib83","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib84","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2007.12.8298","article-title":"High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial","volume":"26","author":"Canioni","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib85","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","article-title":"Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients","volume":"24","author":"Alvaro","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib86","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib87","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib88","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/1078-0432.CCR-06-1734","article-title":"CD8+ T-cell content in diagnostic lymph nodes measured by glow cytometry is a predictor of survival in follicular lymphoma","volume":"13","author":"Wahlin","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2008.07.012_bib89","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.hoc.2008.07.012_bib90","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/1078-0432.CCR-04-0269","article-title":"Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes","volume":"10","author":"Martinez-Delgado","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2008.07.012_bib91","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","article-title":"Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas","volume":"25","author":"Ballester","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.hoc.2008.07.012_bib92","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1182\/blood-2006-12-061507","article-title":"Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome","volume":"110","author":"Shin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib93","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/blood-2006-11-058040","article-title":"Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival","volume":"109","author":"Cerhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib94","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood-2005-01-0272","article-title":"[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome","volume":"106","author":"Haioun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2008.07.012_bib95","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdf256","article-title":"Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma","volume":"13","author":"Spaepen","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib96","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1002\/cncr.22276","article-title":"FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease","volume":"107","author":"Kostakoglu","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2008.07.012_bib97","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/annonc\/mdi272","article-title":"FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma","volume":"16","author":"Mikhaeel","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2008.07.012_bib98","first-page":"50","article-title":"Major Histocompatibility class II (MHCII) and germinal center associated gene expression correlate with overall survival in ritiximab and CHOP-like treated diffuse large B cell lymphoma (DLBCL) patients using formalin fixed paraffin embedded (FFPE) tissues","volume":"110","author":"Rimsza","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.hoc.2008.07.012_bib99","first-page":"49","article-title":"Paraffin-based 6-gene model predicts outcome of diffuse large B-cell lymphoma patients treated with R-CHOP","volume":"110","author":"Malumbres","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.hoc.2008.07.012_bib100","first-page":"49","article-title":"Polymorphisms in one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma (DLBCL)","volume":"110","author":"Cerhan","year":"2007","journal-title":"ASH Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.hoc.2008.07.012_bib101","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3324\/haematol.12251","article-title":"Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas","volume":"93","author":"Jardin","year":"2008","journal-title":"Haematologica"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880800110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880800110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:52:01Z","timestamp":1760183521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985880800110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S088985880800110X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2008.07.012","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Systems for Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2008.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}